NOP World / Novartis / RISK OF / Early Breast Cancer Trialists’ Collaborative Group / MSW / /
Continent
North America / /
Country
United States / /
Event
Product Issues / /
Facility
Clinical Medicine Weill Medical College of Cornell University / /
IndustryTerm
telephone survey / treatment for early breast cancer / therapy for breast cancer / cancer therapy / diagnostic tools / treatment for breast cancer / prevention of breast cancer / BREAST CANCER TREATMENT / treatment of early breast cancer / /
MedicalCondition
tumor / early-stage breast cancer / every three cancer / common cancer / cancer / disease / I cancer / early breast cancer / also enlisted leading breast cancer / INTRODUCTION Breast cancer / sometimes called carcinoma / skin cancers / Breast Cancer / /
Clinical Medicine Weill Medical College / Human Development and Health / MBe Assistant Professor Department / Medicine Harvard Medical School / Harvard School of Public Health Faculty Member / Roper Organization / Dana-Farber Cancer Institute / Cornell University / Society for Women / /
Person
Andrea Gurmankin / Linda Vahdat / Phyllis Greenberger / Ursula Matulonis / / /
Position
Director of Medical Gynecologic Oncology / President and CEO / Assistant Professor / Director of the Breast Cancer Research Program and Associate Professor / /
Life After early Breast Cancer: Science, Perceptions & Communication Surrounding Risk of Recurrence May 2005 Life After early Breast Cancer: Science, Perceptions & Communication Surrounding Risk of Recurrence (Life ABC)